Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mp.17538 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways.
Apoptosis
January 2025
Department of Pathology, Physiology and Pathophysiology, Beijing AnZhen Hospital the Key Laboratory of Remodeling Related Cardiovascular Diseases, School of Basic Medical Sciences, Capital Medical University, Ministry of Education, No. 10 Xitoutiao You An Men, Beijing, 100069, China.
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Front Immunol
December 2024
Immunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrection to: Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.
Neurol Sci
December 2024
Neuroimmunology Unit, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell, 106, 46026, Valencia, Spain.
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications.
Pharmacoeconomics
December 2024
Medical Sciences Precinct, Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!